Microencapsulation of protein into biodegradable matrix: A smart solution cross-linking technique

Journal of Microencapsulation

Volumn 30, Issue 3, 2013, Pages 274-282

  Bejugam, Naveen K ^a,b   Gayakwad, Sanjay G ^b,c   Uddin, Akm N ^b,d   D'Souza, Martin J ^b  

^a ONYX PHARMACEUTICALS   (United States)

^b MERCER UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND EASTERN SHORE   (United States)

^d Teva Pharmaceuticals   (United States)

Author keywords

Albumin; Cross linking; Glutaraldehyde; Lysozyme; Microencapsulation; Microspheres

Indexed keywords

BISULFITE; BOVINE SERUM ALBUMIN; GLUTARALDEHYDE; LYSOZYME; MICROSPHERE; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG FORMULATION; IMMUNOGENICITY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; SPRAY DRYING; STRUCTURE ACTIVITY RELATION; ZETA POTENTIAL;

BIOCOMPATIBLE MATERIALS; DRUG COMPOUNDING; MURAMIDASE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84875835140     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2012.720724     Document Type: Article

References (42)

1. Akers MJ, Nail SL. Top 10 current technical issues in parenteral science. Pharm Technol, 1994;18: 26-36.
2. Arshady R. Albumin microspheres and microcapsules: Methodology of manufacturing techniques. J Controlled Release, 1990;14: 111-31. (Pubitemid 20353562)
3. Banga AK. 2006. Therapeutic peptides and proteins: Formulation, processing, and delivery systems. Boca Raton, FL: CRC/Taylor & Francis.
4. Barrett TJ, Blake PA, Brown SL, Hoffman K, Llort JM, Feeley JC. Enzymelinked immunosorbent assay for detection of human antibodies to Salmonella typhi Vi antigen. J Clin Microbiol, 1983;17: 625-7. (Pubitemid 13160866)
5. Bauer HH, Muller M, Goette J, Merkle HP, Fringeli UP. Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. Biochemistry, 1994;33: 12276-82. (Pubitemid 24328047)
6. Bejugam NK, Uddin AN, Gayakwad SG, D'Souza MJ. Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsulation, 2008;25: 577-83.
7. Bosse D, Praus M, Kiessling P, Nyman L, Andresen C, Waters J, Schindel F. Phase I comparability of recombinant human albumin and human serum albumin. J Clin Pharmacol, 2005;45: 57-67.
8. Broadhead J, Rouan SK, Hau I, Rhodes CT. The effect of process and formulation variables on the properties of spray-dried beta-galactosidase. J Pharm Pharmacol, 1994;46: 458-67. (Pubitemid 24179539)
9. Burger JJ, Tomlinson E, Mulder EMA, McVie JG. Albumin microspheres for intra-arterial tumour targeting. I. Pharmaceutical aspects. Int J Pharm, 1985;23: 333-44. (Pubitemid 15106921)
10. Burgess DJ, Davis SS, Tomlinson E. Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids. Int J Pharm, 1987;39: 129-36. (Pubitemid 17123100)
11. Cauchy M, D'Aoust S, Dawson B, Rode H, Hefford MA. Thermal stability: A means to assure tertiary structure in therapeutic proteins. Biologicals, 2002;30: 175-85. (Pubitemid 36268970)
12. Chaubal MV. Human serum albumin as a pharmaceutical excipient. Drug Deliv Technol, 2005;5: 22-3.
13. Chen CQ, Lin W, Coombes AG, Davis SS, Illum L. Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method. J Microencapsulation, 1994;11: 395-407. (Pubitemid 24209454)
14. Evans S, Grassam P. Considerations for parenteral dosage form development of natural alpha interferon. J Parenter Sci Technol, 1986;40: 83-7. (Pubitemid 16068423)
15. Ferry BL, Misbah SA, Stephens P, Sherrell Z, Lythgoe H, Bateman E, Banner C, Jones J, Groome N, Chapel HM. Development of an anti- Salmonella typhi Vi ELISA: Assessment of immunocompetence in healthy donors. Clin Exp Immunol, 2004;136: 297-303. (Pubitemid 38543449)
16. Gorin G, Wang SF, Papapavlou L. Assay of lysozyme by its lytic action on M. lysodeikticus cells. Anal Biochem, 1971;39: 113-27.
17. Green MD, D'Souza MJ, Holbrook JM, Wirtz RA. In vitro and in vivo evaluation of albumin-encapsulated primaquine diphosphate prepared by nebulization into heated oil. J Microencapsulation, 2004;21: 433-44. (Pubitemid 39377785)
18. Grossowicz N, Ariel M. Methods for determination of lysozyme activity. Methods Biochem Anal, 1983;29: 435-46.
19. Haswani D. 2005. Evaluation of microencapsulated gentamicin on Escherichia coli in Gram negative sepsis, PhD Dissertation, Department of Pharmaceutical Sciences, Mercer University.
20. Haswani DK, Nettey H, Oettinger C, D'Souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J Microencapsulation, 2006;23: 875-86. (Pubitemid 46332099)
21. He J, Feng M, Zhou X, Ma S, Jiang Y, Wang Y, Zhang H. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm, 2011;416: 69-76.
22. Jena I. 2005. Determination of secondary structure in proteins by Fourier transform infrared spectroscopy (FT-IR). Image Library of Biological Macromolecules.
23. Jordan SL, Russo MR, Blessing RL, Theis AB. Inactivation of glutaraldehyde by reaction with sodium bisulfite. J Toxicol Environ Health, 1996;47: 299-309.
24. Jyothi NV, Prasanna PM, Sakarkar SN, Prabha KS, Ramaiah PS, Srawan GY. Microencapsulation techniques, factors influencing encapsulation efficiency. J Microencapsulation, 2010;27: 187-97.
25. Kim DH, Jun SW, Kim MS, Lee S, Hwang SJ, 2005. Micronisation of lysozyme suitable for pulmonary drug delivery using solution enhanced dispersion by supercritical fluids. Miami, FL: Controlled Release Society.
26. Labrude P, Rasolomanana M, Vigneron C, Thirion C, Chaillot B. Protective effect of sucrose on spray drying of oxyhemoglobin. J Pharm Sci, 1989;78: 223-9. (Pubitemid 19079847)
27. Liao YH, Brown MB, Martin GP. Turbidimetric and HPLC assays for the determination of formulated lysozyme activity. J Pharm Pharmacol, 2001;53: 549-54. (Pubitemid 32396547)
28. Linders LJM, Meerdink G, Van't Riet K. Influence of temperature and drying rate on the dehydration inactivation of Lactobacillus plantarum. Trans IchemE, 1996;74: 110-4. (Pubitemid 126419822)
29. Malzert A, Boury F, Renard D, Robert P, Proust JE, Benoit JP. Influence of some formulation parameters on lysozyme adsorption and on its stability in solution. Int J Pharm, 2002;242: 405-9.
30. Morris NJ, Warburton B. Three-ply walled w/o/w microcapsules formed by a multiple emulsion technique. J Pharm Pharmacol, 1982;34: 475-9. (Pubitemid 12029561)
31. Natsume H, Sugibayashi K, Kazuhiko K, Morimoto Y, Shibata T, Fujimoto S. Preparation and evaluation of biodegradable albumin microspheres containing mitomycin C. Int J Pharm, 1990;58: 79-87. (Pubitemid 20034231)
32. Nettey H, Haswani D, Oettinger CW, D'Souza MJ. Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying. J Microencapsulation, 2006;23: 632-42. (Pubitemid 44803856)
33. Orive G, Carcaboso AM, Hernandez RM, Gascon AR, Pedraz JL. Biocompatibility evaluation of different alginates and alginate-based microcapsules. Biomacromolecules, 2005;6: 927-31. (Pubitemid 40467838)
34. Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TM, de Vos P, Hortelano G, Hunkeler D, Lacik I, Shapiro AM, et al. Cell encapsulation: Promise and progress. Nat Med, 2003;9: 104-7. (Pubitemid 36098269)
35. Shah MV, de Gennaro MD, Suryakasuma H. An evaluation of albumin microcapsules prepared using a multiple emulsion technique. J Microencapsulation, 1987;4: 223-38. (Pubitemid 17137842)
36. Silva CJSM, Sousa F, Gubitz G, Cavaco-Paulo A. Chemical modifications on proteins using glutaraldehyde. Food Tech Biotechnol, 2004;42: 51-6. (Pubitemid 38424461)
37. Tzannis ST, Prestrelski SJ. Activity-stability considerations of trypsinogen during spray drying: Effects of sucrose. J Pharm Sci, 1999a;88: 351-9. (Pubitemid 29116105)
38. Tzannis ST, Prestrelski SJ. Moisture effects on protein-excipient interactions in spray-dried powders. Nature of destabilizing effects of sucrose. J Pharm Sci, 1999b;88: 360-70. (Pubitemid 29116106)
39. US Department of Labor, OSHA, 1987. OSHA analytical methods manual, Method 64, Glutaraldehyde. Salt Lake City, UT: OSHA Analytical Laboratory.
40. Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, Zhang Z. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxelloaded bovine serum albumin nanoparticles. Int J Nanomedicine, 2010a;5: 669-77.
41. Zhao L, Yang B, Dai X, Wang X, Gao F, Zhang X, Tang J. Glutaraldehyde mediated conjugation of amino-coated magnetic nanoparticles with albumin protein for nanothermotherapy. J Nanosci Nanotechnol, 2010b;10: 7117-20.
42. Zolle I, Rhodes BA, Wagner HN. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. Int J Appl Radiat Isot, 1970;21: 155-67.